Gene · 406921
NIH grants1,675
NIH grants whose papers are about the gene, through NIH's grant-paper links.
181 to 200 of 1,675
Download this page as JSON| Grant | Title | MIR132 papers | Newest fiscal year |
|---|---|---|---|
| R01NS095799 | Mechanisms underlying Tip60 HAT action in neuroprotection of cognitive function | 1 | 2025 |
| R01NS097542 | RNA decay in amyotrophic lateral sclerosis and frontotemporal lobar degeneration | 1 | 2025 |
| R01NS115834 | The functions of the zinc finger protein ZPR1 in R-loop metabolism and neurodegeneration. | 1 | 2025 |
| R01NS122222 | Calcium Channels in Glioblastoma | 1 | 2025 |
| R01NS125318 | Targeting RNA Splicing in Glioma | 1 | 2025 |
| R01NS125437 | Amyloid beta peptides and type-2 diabetes sequelae synergistically inhibit insulin signaling and trafficking at the blood brain barrier | 1 | 2025 |
| R24AA012885 | Integrative Liver Cell Core | 1 | 2025 |
| R24AA019431 | Monkey Alcohol Tissue Research Resource (MATRR) | 1 | 2025 |
| R24HD000836 | Laboratory of Developmental Biology | 1 | 2025 |
| R25AI147376 | UC San Diego Raising Advancement and Parity for Infectious Disease Researchers (RAPID) Faculty Development Program | 1 | 2025 |
| R25CA023944 | PEDIATRIC ONCOLOGY EDUCATION (YEARS 38 - 42) | 1 | 2025 |
| R25MH086466 | PRIMING THE PUMP: TRAINING PHYSICIAN-SCIENTISTS IN TRANSLATIONAL PSYCHIATRY | 1 | 2025 |
| R35GM118103 | Recognition of Cellular Targets by single and double-stranded nucleic acids | 1 | 2025 |
| R35GM133794 | Advanced molecular engineering approach for understanding extracellular vesicle in vivo trafficking mechanism | 1 | 2025 |
| R35GM140845 | Expression genetics of pharmacogenes | 1 | 2025 |
| R35GM143014 | Nucleic acid modulators and theranostics for ADAR | 1 | 2025 |
| R37AA012446 | Fetal Alcohol Effects and Choline Intervention | 1 | 2025 |
| T32AA025606 | Development and Neuroadaptations in Alcohol and Addictions (DNA2) | 1 | 2025 |
| T32AG020494 | Training in the Neurobiology of Aging and Alzheimer's Disease | 1 | 2025 |
| T32AG055378 | Neuroscience of Aging, Neurodegeneration and Alzheimer's Disease | 1 | 2025 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/406921/grants?page=10